1. Sternberg CN, CalabrO F, Pizzocaro G, et al. : Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy. Cancer 92 : 2993-2998, 2001.
2. Pycha A, Grbovic M, Posch B, et al. : Paclitaxel and carboplatin in patients with metastatic transitional cell cancer of the urinary tractUrology 53 : 510-515, 1999.
4. Bellmunt J, Albanell J, Paz-Ares L, et al. ; Spanish Oncology Genitourinary Group. : Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine. Cancer 95 : 751-757, 2002.